Ophthalmology news in 2019 included FDA approvals and breakthrough study results.
Here are the 10 most read articles of the year on Healio.com/OSN:
Phase 2a study shows improved vision with stem cell therapy for retinitis pigmentosa
Human retinal progenitor cell therapy from ReNeuron Group showed positive preliminary results in the company’s ongoing phase 1/2a clinical trial involving patients with retinitis pigmentosa. Read more.
Read follow-up reporting here.
FDA approves Alcon’s AcrySof IQ PanOptix trifocal IOL
PanOptix, which is already available in more than 70 countries, has been
Uncategorized